Qinlock and Urticaria - a phase IV clinical study of FDA data

Summary:

Urticaria is reported as a side effect among people who take Qinlock (ripretinib), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Ayvakit, and have Gastrointestinal stromal tumor.

The phase IV clinical study analyzes which people have Urticaria when taking Qinlock. It is created by eHealthMe based on reports of 3,803 people who have side effects when taking Qinlock from the FDA, and is updated regularly.

What is Qinlock?

Qinlock has active ingredients of ripretinib. eHealthMe is studying from 3,803 Qinlock users. Check the latest studies of Qinlock.

What is Urticaria?

Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,612 drugs and 2,953 conditions by eHealthMe. Check the latest studies of Urticaria.

On Aug, 09, 2026

3,803 people reported to have side effects when taking Qinlock.
Among them, 16 people (0.42%) have Urticaria.

Among these 16 people:

How long have people been on Qinlock when they have Urticaria? *

What is the gender of people who have Urticaria when taking Qinlock? *

female: 68.75 %
male: 31.25 %

What is the age of people who have Urticaria when taking Qinlock? *

What are other drugs people take besides Qinlock? *

Ayvakit: 3 people, 18.75%
Amlodipine: 1 person, 6.25%

What are other side effects people have besides Urticaria? *

Hair Loss: 8 people, 50.00%
Rashes (redness): 8 people, 50.00%
Itching: 8 people, 50.00%
Melanocytic Naevus (a type of lesion that contains nevus cells (a type of melanocyte)): 5 people, 31.25%
Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 5 people, 31.25%
Neuropathy Peripheral (surface nerve damage): 4 people, 25.00%
Trigger Finger: 4 people, 25.00%
Hair Texture Abnormal: 4 people, 25.00%
Drug Intolerance (drug sensitivity): 4 people, 25.00%
Pain Of Skin: 3 people, 18.75%

What are the existing conditions these people have? *

Gastrointestinal Stromal Tumor: 15 people, 93.75%
Tumor: 1 person, 6.25%
High Blood Pressure: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Qinlock and have Urticaria?

- Check whether Urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Qinlock:

Qinlock (3,803 reports)

Urticaria treatments and more:

Urticaria (173,777 reports)

Browse all side effects of Qinlock:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urticaria:

Urticaria (2,612 drugs)

Browse all the conditions that are associated with Urticaria:

Urticaria (2,953 conditions)

Related publications that referenced our studies

Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ripretinib (the active ingredients of Qinlock) and Qinlock (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.